Healthcare / Health Information ServicesNasdaqGS
$20.25
+0.72 (+3.69%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $19.2M · quality 45.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$456M
P/E
49.4x
↑EV/EBITDA
17.5x
↑ROE
82.9%
↑Gross Margin
61.9%
↑Debt/Equity
5.65
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+5.6%
FCF CAGR
+2.4%
FCF margin
11.5%
FCF / Net income
1.36x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $137.4M · net income $11.6M · FCF $15.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $137.4M | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M | $133.3M | $128.0M | $119.7M | $117.6M | $109.4M | $102.3M | $98.8M | $92.6M | $86.4M | $75.8M | $63.4M | $57.7M |
| Net Income | $11.6M | $11.6M | $24.8M | $31.0M | $31.8M | $37.5M | $37.3M | $32.4M | $30.0M | $22.9M | $20.5M | $17.6M | $18.2M | $15.5M | $15.1M | $11.6M | $11.6M | $8.5M |
| EBITDA | $30.2M | $30.2M | $41.3M | $46.7M | $49.3M | — | — | $48.6M | $40.7M | $38.8M | $35.4M | $30.6M | $32.1M | $28.5M | $27.4M | $23.8M | $18.6M | $17.5M |
| EPS | 0.50 | 0.50 | 1.04 | 1.25 | 1.27 | 1.46 | 1.45 | 1.26 | — | — | — | — | — | — | 2.17 | 1.69 | 1.26 | 1.26 |
| Gross Margin | 61.9% | 61.9% | 60.2% | 62.3% | 62.4% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 16.4% | 16.4% | 24.6% | 27.0% | 30.7% | 34.0% | 32.0% | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | 26.8% | 26.3% | 24.7% | 21.9% | 23.7% |
| Net Margin | 8.4% | 8.4% | 17.3% | 20.8% | 21.0% | 25.3% | 28.0% | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | 16.7% | 17.4% | 15.3% | 18.2% | 14.7% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 5.65 | 5.65 | 2.00 | 0.75 | 0.31 | 0.31 | 0.41 | 0.91 | 1.79 | 0.01 | 0.01 | 0.04 | 0.07 | 0.11 | 0.22 | 0.26 | — | — |
| Current Ratio | 0.52 | 0.52 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $15.7M | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M | $36.7M | $36.3M | $33.9M | $23.5M | $22.9M | $18.9M | $23.7M | $17.1M | $16.8M | $15.7M | $13.1M | $10.8M |
| Returns | ||||||||||||||||||
| ROE | 82.9% | 82.9% | 79.2% | 63.3% | 44.1% | 43.9% | 57.9% | 98.5% | 157.5% | 25.5% | 24.8% | 23.7% | 20.7% | 21.6% | 26.6% | 20.8% | 23.8% | 19.2% |
| Valuation | ||||||||||||||||||
| P/E | 49.39 | 49.39 | 17.05 | 30.50 | 31.64 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 17.48 | 17.48 | 11.61 | 20.78 | 20.36 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 32.42 | 32.42 | 13.46 | 19.22 | 13.97 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | -4.0% | -4.0% | -3.7% | -2.0% | — | 11.0% | 4.1% | 6.9% | 1.8% | 7.5% | 6.9% | 3.5% | 6.7% | 7.1% | 14.1% | 19.5% | 9.9% | — |
| EPS Growth | -51.9% | -51.9% | -16.8% | -1.6% | — | 0.7% | 15.1% | — | — | — | — | — | — | — | 28.4% | 34.1% | 0.0% | — |
| Dividend Yield | 3.1% | 3.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
53.2%
EPS terminal req.
$1.80
Spread vs growth
-105.1%
5Y implied EPS CAGR
34.2%
EPS terminal req.
$2.17
Spread vs growth
-86.1%
10Y implied EPS CAGR
21.5%
EPS terminal req.
$3.50
Spread vs growth
-73.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+53.0%
Start / end P/E
13.0x → 40.5x
EPS bridge
1.04 → 0.50
Residual
-110.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.